Analyzing Atrion (ATRI) and Becton Dickinson and (BDX)

Atrion (NASDAQ:ATRI) and Becton Dickinson and (NYSE:BDX) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Risk and Volatility

Atrion has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500. Comparatively, Becton Dickinson and has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500.

Earnings and Valuation

This table compares Atrion and Becton Dickinson and’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Atrion $146.60 million 10.04 $36.59 million N/A N/A
Becton Dickinson and $15.98 billion 4.17 $311.00 million $11.01 22.50

Becton Dickinson and has higher revenue and earnings than Atrion.

Institutional & Insider Ownership

66.9% of Atrion shares are owned by institutional investors. Comparatively, 84.0% of Becton Dickinson and shares are owned by institutional investors. 22.5% of Atrion shares are owned by insiders. Comparatively, 0.1% of Becton Dickinson and shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and recommmendations for Atrion and Becton Dickinson and, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Atrion 0 0 0 0 N/A
Becton Dickinson and 0 5 6 0 2.55

Becton Dickinson and has a consensus price target of $254.09, suggesting a potential upside of 2.58%. Given Becton Dickinson and’s higher probable upside, analysts clearly believe Becton Dickinson and is more favorable than Atrion.

Dividends

Atrion pays an annual dividend of $5.40 per share and has a dividend yield of 0.7%. Becton Dickinson and pays an annual dividend of $3.08 per share and has a dividend yield of 1.2%. Becton Dickinson and pays out 28.0% of its earnings in the form of a dividend. Atrion has increased its dividend for 16 consecutive years and Becton Dickinson and has increased its dividend for 47 consecutive years. Becton Dickinson and is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Profitability

This table compares Atrion and Becton Dickinson and’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Atrion 23.19% 18.01% 16.26%
Becton Dickinson and 5.69% 14.65% 5.78%

Summary

Becton Dickinson and beats Atrion on 8 of the 15 factors compared between the two stocks.

About Atrion

Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise MPS2 myocardial protection system that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products that are used in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measures the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers, as well as other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

About Becton Dickinson and

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, monoclonal antibodies and kits, reagent systems, bench-side solutions, and molecular indexing and next-generation sequencing sample preparation products, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, thoracic and abdominal drainage, and surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply